4-chloro-N-(3-chloro-4-oxo-1(4H)-naphthalenylidene)benzenesulfonamide → (NE)-N-[3-(1-methyltetrazol-5-yl)sulfanyl-4-oxonaphthalen-1-ylidene]-4-phenylbenzenesulfonamide

Participants

Role	Name	HCID	Charge
Reactant	4-chloro-N-(3-chloro-4-oxo-1(4H)-naphthalenylidene)benzenesulfonamide	HCID 9601233	—
Reactant	(NE)-N-[3-(1-methyltetrazol-5-yl)sulfanyl-4-oxonaphthalen-1-ylidene]-4-phenylbenzenesulfonamide	HCID 46908285	—
Reactant	HCID 178527894	HCID 178527894	—
Product	(NE)-N-[3-(1-methyltetrazol-5-yl)sulfanyl-4-oxonaphthalen-1-ylidene]-4-phenylbenzenesulfonamide	HCID 46908285	57.4%
Product	HCID 178516926	HCID 178516926	—

Reaction Steps

(E)-N-(3-(1H-1,2,4-triazol-3-ylthio)-4-oxonaphthalen-1(4H)-ylidene)-4-chlorobenzenesulfonamide (13af) was prepared according to the procedure for 13x except using 12e and 3-mercapto-1,2,4-triazole, affording 43.8 mg (57.4%) title compound as a yellow solid.

Provenance & Evidence

DOI	10.6084/m9.figshare.5104873.v1
Patent number	US08466157B2
Source dataset	uspto-grants-2013_06
ORD ID	ord-81c9d3d428974b34a516913711aab649
Source note	uspto-grants-2013_06